Skip to main content
. 2002 Mar;13(3):1058–1070. doi: 10.1091/mbc.01-06-0298

Figure 2.

Figure 2

Western blot analysis of CAP15/CAP17 expression. Total lysates of 2 × 107 (A–D) or 2 × 106 (E) T. brucei procyclic (PF) or bloodstream (BF) forms were probed with anti-CAP15 serum (anti-CAP15.NA) (A); anti-CAP15 serum adsorbed against the recombinant CAP17 (anti-CAP15.A) (B); anti-CAP17 serum (anti-CAP17.NA) (C); and anti-CAP17 serum adsorbed against the recombinant CAP15 (anti-CAP17.A) (D). The positions of CAP15 and CAP17 are indicated on the left margin, and the molecular weight markers are indicated between D and E.